Answers are grounded in this paper and cite their sources.
New hydrogel formulation improves bioavailability of estetrol in a safe manner, suggesting potential for effective treatment.
The estetrol-containing HEC-based and HPβCD-based vaginal hydrogel is nontoxic, and the estetrol is readily bioavailable. The formulation enhances estetrol bioavailability while ensuring localized, controlled release and optimizing therapeutic efficacy. Future clinical trials are required to confirm in vivo effectiveness and long-term safety.
No takes yet. Share an insight, caveat, or question.
Takacs et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: